Sol-Gel Technologies SLGL
NASDAQ SLGL
$72.00 -1.00 (-1.37%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sol-Gel Technologies (SLGL) Return on Sales [ROS] (2018 - 2026)

Updated

Sol-Gel Technologies (SLGL) recorded Return on Sales [ROS] of -704.23% in Q2 2026, down 769.29 percentage points from 65.06% a year earlier and down 4273.67 percentage points from the prior quarter.

Analysis

Sol-Gel Technologies (SLGL) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

On a TTM basis, Sol-Gel Technologies' Return on Sales [ROS] came in at -557.44% as of Jun 30, 2026, down 613.31 percentage points year-over-year; for FY2025, it came in at -38.88%, up 65.25 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of +305.81 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -104.13% in FY2024 (+1781.65 pp), -1885.78% in FY2023 (-1467.44 pp), -418.34% in FY2022 (-430.80 pp) and 12.47% in FY2021 (+357.16 pp).
  • Quarterly Return on Sales [ROS] has ranged from -6205.00% in Q4 2022 to 198333.33% in Q1 2022 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in four of the last eight quarters, with an average year-over-year change of +437.94 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 197730.77 percentage points in Q1 2022, against a drop of 194645.67 percentage points in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at 3569.44% (Q1 2026), -490.09% (Q4 2025) and -1572.00% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Sol-Gel Technologies 200.60 Mn 55.02 Mn - -704.23%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -704.23%
Mar 31, 2026 3,569.44%
Dec 31, 2025 -490.09%
Sep 30, 2025 -1,572.00%
Jun 30, 2025 65.06%
Mar 31, 2025 879.63%
Dec 31, 2024 -2,193.88%
Sep 30, 2024 -15.44%
Jun 30, 2024 29.89%
Mar 31, 2024 1,440.34%
Dec 31, 2023 -1,209.62%
Sep 30, 2023 -2,961.03%
Jun 30, 2023 -1,098.82%
Mar 31, 2023 3,687.67%
Dec 31, 2022 -6,205.00%
Sep 30, 2022 -1,388.89%
Jun 30, 2022 13.16%
Mar 31, 2022 198,333.33%
Dec 31, 2021 67.08%
Sep 30, 2021 95.21%
API Access

Sol-Gel Technologies Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SLGL&period=max&api_key=YOUR_API_KEY